[1]朱玉辉,翟丽杰,张双福,等.灯盏细辛注射液联合尤瑞克林治疗气虚血瘀型早期急性缺血性脑卒中临床研究*[J].陕西中医,2020,(5):609-611.[doi:DOI:10.3969/j.issn.10007369.2020.05.015]
　ZHU Yuhui,ZHAI Lijie,WANG Shiji,et al.Breviscapine injection combined with urinary kallidinogenase for injection in early rehabilitation of acute ischemic stroke with qi deficiency and blood stasis[J].,2020,(5):609-611.[doi:DOI:10.3969/j.issn.10007369.2020.05.015]
点击复制

灯盏细辛注射液联合尤瑞克林治疗气虚血瘀型早期急性缺血性脑卒中临床研究*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年5期
页码:
609-611
栏目:
临床研究
出版日期:
2020-05-05

文章信息/Info

Title:
Breviscapine injection combined with urinary kallidinogenase for injection in early rehabilitation of acute ischemic stroke with qi deficiency and blood stasis
作者:
朱玉辉1; 翟丽杰1; 张双福2; 王奭骥3; 柴 劲1△
1.吉林大学第二医院药学部(长春 130041); 2.上海杨思医院(上海 200126); 3.吉林大学第一医院重症医学科(长春 130000)
Author(s):
ZHU Yuhui; ZHAI Lijie; WANG Shiji; et al.
Department of Pharmacy,Second Hospital of Jilin University(Changchun 130041)
关键词:
急性缺血性脑卒中;  灯盏细辛;  尤瑞克林;  气虚血瘀;  局部脑血流丧失指数;  血清脑源性神经营养因子
Keywords:
Acute ischemic stroke;  Erigeron breviscapine injection;  Urinary kallidinogenase for injection;  Qi deficiency and blood stasis;  Ischemic stroke;  rCBFLI;  BDNF
分类号:
R743.3
DOI:
DOI:10.3969/j.issn.10007369.2020.05.015
文献标志码:
A
摘要:
目的:探究灯盏细辛注射液联合尤瑞克林用于气虚血瘀型急性缺血性脑卒中的早期康复价值。方法:将164例气虚血瘀型急性缺血性脑卒中患者以随机数字表法分为尤瑞克林组、联合组,各82例,两组均采用常规治疗,尤瑞克林组使用尤瑞克林注射液,联合组在尤瑞克林组基础上联合灯盏细辛注射液,比较两组不同时间点的生活能力等级、局部脑血流丧失指数、血清脑源性神经营养因子。结果:联合组患者治疗后14 d的生活依赖程度显著低于尤瑞克林组(P<0.01); 联合组患者治疗后7 d、14 d的局部脑血流丧失指数均显著低于尤瑞克林组(P<0.05); 联合组患者治疗后3 d、7 d、14 d的血清脑源性神经营养因子浓度水平均显著高于尤瑞克林组(P<0.05)。两组患者不良反应情况无明显差异(P>0.05)。结论:气虚血瘀型急性缺血性脑卒中应用灯盏细辛联合尤瑞克林注射液,能够有效降低局部脑血流丧失指数,改善脑源性神经营养因子水平,降低生活依赖程度,患者早期康复效果更佳。
Abstract:
Objective:To explore the value of erigeron breviscapine injection combined with urinary kallidinogenase for injection in the early rehabilitation of acute ischemic stroke with qi deficiency and blood stasis.Methods:A total of 164 patients with acute ischemic stroke with qi deficiency and blood stasis were randomly divided into the eureklin group and the combined group,with 82 cases each.Both groups received conventional treatment.The eureklin group combined with urinary kallidinogenase for injection,and the joint group combined with breviscapine injection on the basis of the eureklin group.The living ability level,local cerebral blood flow loss index and serum brain-derived neurotrophic factor of the two groups at different time points were compared.Results:14 d after treatment,the living dependence of patients in the joint group was significantly lower than that in the eureklin group(P<0.01).The index of local cerebral blood flow loss in the combined group was significantly lower than that in the eureklin group on day 7 and 14 after treatment(P<0.05).The serum levels of brain-derived neurotrophic factor(BDNF)in the joint group were significantly higher than those in the eurekline group(P<0.05).Conclusion:The application of breviscapine combined with eureklin injection in acute ischemic stroke with qi deficiency and blood stasis can effectively reduce the index of local cerebral blood flow loss,improve the level of brain-derived neurotrophic factor,reduce the degree of life dependence,and the early recovery effect of patients is better.

参考文献/References:

[1] 中国老年医学学会急诊医学分会,中华医学会急诊医学分会卒中学组,中国卒中学会急救医学分会,等.急性缺血性脑卒中急诊急救中国专家共识(2018版)[J].中华急诊医学杂志,2018,27(7):721-728.
[2] 王爱丽,王 倩.补阳还五汤联合丹红注射液对缺血性脑卒中气虚血瘀证神经功能及血清神经生长因子、脑源性神经细胞营养因子的影响[J].陕西中医,2019,40(6):692-695.
[3] 付 巍,谢立栋,李 卓.注射用尤瑞克林治疗大动脉粥样硬化型急性期脑梗死的临床疗效观察[J].中华急诊医学杂志,2019,28(7):905-907.
[4] 王晓东,任瑞芳,王桂华,等.脑梗死发病24～72 h内启用尤瑞克林的预后研究[J].中华急诊医学杂志,2019,28(6):780-783.
[5] 中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中华神经科杂志,2010,43(2):146-153.
[6] 中国中西医结合学会急救医学专业委员会,方邦江,李志军,等.中国急性缺血性脑卒中中西医急诊诊治专家共识[J].中华危重病急救医学,2018,30(3):193-197.
[7] 尚立宏,王茂德.动静脉联合溶栓治疗急性缺血性脑血管病的临床效果观察[J].陕西医学杂志,2017,46(8):1078-1079.
[8] 赵丽丽,姜立刚,唐 晶,等.尤瑞克林治疗短暂性脑缺血发作的疗效与安全性评价[J].中华急诊医学杂志,2019,28(7):903-905.
[9] 谭 辉,尹婷婷,何 玲,等.气虚血瘀证脑缺血再灌注病证结合大鼠模型的建立与评价[J].中国中西医结合杂志,2018,38(7):832-837.
[10] 中国老年医学学会急诊医学分会,中华医学会急诊医学分会卒中学组,中国卒中学会急救医学分会,等.急性缺血性脑卒中急诊急救中国专家共识(2018)[J].临床急诊杂志,2018,13(6):351-359.
[11] 伍珊娜,刘振杰,章从恩,等.基于谱效关系的灯盏细辛体外抗血小板聚集活性成分研究[J].中草药,2017,48(24):5179-5185.
[12] 李佶操,唐绍微,伍怡颖,等.黄芪-灯盏细辛组分最佳配比对脑缺血大鼠的保护作用与机制[J].中药药理与临床,2019,35(2):106-110.
[13] 刘燕妮,高 静.补益肝肾方对缺血性脑卒中模型大鼠TrkB表达的影响[J].延安大学学报(医学科学版),2018,16(2):12-15.
[14] Guo C,Wang S,Duan J,et al.Protocatechualdehyde protects against cerebral ischemia-reperfusion-induced oxidative injury via protein kinase Cε/Nrf2/HO-1 pathway[J].Molecular Neurobiology,2017,54(2):833-845.
[15] 惠 晶,刘利宁.丹参多酚酸盐联合依达拉奉治疗急性脑卒中的疗效分析[J].中国急救复苏与灾害医学杂志,2019,14(12):1194-1197.

相似文献/References:

[1]屈雅娟,张敬芳,孙 旗,等.灯盏细辛联合依帕司他对糖尿病肾病模型大鼠的治疗作用及机制[J].陕西中医,2022,(10):1337.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.004]
　QU Yajuan,ZHANG Jingfang,SUN Qi,et al.Therapeutic effect and mechanism of erigeron breviscapus combined with epalrestat on diabetic nephropathy model rats[J].,2022,(5):1337.[doi:DOI:10.3969/j.issn.1000-7369.2022.10.004]

备注/Memo

备注/Memo:
*吉林省卫生和计划生育委员会项目(2016Z071)
更新日期/Last Update: 2020-05-14